A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis

Immune response to biologics treatment, while widely reported, yet fails to correlate with clinical outcomes and assay to assay comparison is often not possible. Hence, we developed a new peptide based-detection assay to stratify pediatric patients with juvenile idiopathic arthritis (JIA) or chronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Rusche, Hendrik, Marrani, Edoardo, Real-Fernandez, Feliciana, Ponti, Roberta, Terzani, Francesco, Maccora, Ilaria, Monasson, Olivier, Mastrolia, Maria Vincenza, Peroni, Elisa, Pagnini, Ilaria, Cimaz, Rolando, Papini, Anna Maria, Simonini, Gabriele, Rovero, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360964/
https://www.ncbi.nlm.nih.gov/pubmed/34385564
http://dx.doi.org/10.1038/s41598-021-95920-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360964/
https://www.ncbi.nlm.nih.gov/pubmed/34385564
http://dx.doi.org/10.1038/s41598-021-95920-9

Ejemplares similares